Rebecca Dzombak

Rebecca Dzombak is a science writer and editor based in Washington State. She earned her Ph.D. in Earth and Environmental Sciences at the University of Michigan and has since been covering many aspects of the natural world, from conservation to cancer, for outlets such as The New York Times, National Geographic, and Scientific American. 
Collage of images showcasing a young man, a young woman, a doctor and a mother with a baby
Illuminate

Closing the Gap

Rogel researchers are studying how to improve cancer care for adolescents and young adults ages 15–39, a group facing unique physical, emotional, social, and life-transition challenges. Their work focuses on tailoring treatment and support to better meet the needs of these patients.
 clear see through pill floating with other little pills behind in blue teal pink background
Health Lab

Stopping Ewing sarcoma relapses where they start

Research on stopping Ewing sarcoma relapses through Michigan Medicine.
 An illustration showing how patients' medical information becomes anonymous data which demonstrates trends, commonalities, etc.
Illuminate

Big Data, Better Cancer Care

University of Michigan Rogel Cancer Center researchers are using patient-centered health data science to improve cancer care. Their work focuses on secure patient data collection, storage, and analysis; personalized treatments; earlier detection of adverse reactions; large digital cancer databases; and more equitable, human-centered oncology care.
Illuminate

Wearing your heart(rate) on your sleeve

Wearable health technology, such as heart rate sensors, can enable real-time health data collection in an accessible and equitable way.
 frozen dial with ice on it with red dial
Health Lab

Enzyme identified as new therapeutic target for “cold” tumors

A study identifies an enzyme as a new therapeutic target for “cold” tumors.
 stained glass green blue purple orange pink
Health Lab

Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment

A study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas.
 An illustration of the inside of a skull with the brain in color
Illuminate

A Path of Hope for Glioblastoma Treatment

The University of Michigan has become a world-renowned institution for treating aggressive brain tumors. From identifying deadly tumors sooner, understanding the biology of how and why they grow, and uncovering promising new treatments, Rogel researchers are carving a path that creates hope for patients, becoming a hub of innovation in the process.